Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Phase I safety studies report good tolerability with no serious adverse events at tested doses [9]
This recommendation is conservative, based on BPC-157's pharmacokinetics: absorption and distribution occur within 1-2 hours of subcutaneous injection
For additional information or questions, please contact us
Gently swirl the vial in a circular motion
Published online June 27, 2014
US$ 29.48
US$ 26.95
US$ 24.45
